The bank's lead analyst recognizes the importance of getting in early with potentially game-changing drug development.

This article was reviewed by Darragh O’Carroll, MD. GLP-1 for Weight Loss: Everything You Need to Know Key takeaways: GLP-1s ...

Conduent Incorporated , a global technology-driven business solutions and services company, today announced the launch of a new GenAI-powered reportable event detection solution that dramatically ...

Doctors are sounding the alarm on popular “natural” sweeteners hiding in your kitchen. New research reveals one surprising factor in childhood that could shape your heart health for life — and the ...

Novo Nordisk today presented new data from the OASIS 4 phase 3 trial that explored a variety of patients and hypotheses, adding to the body of evidence supporting this potential treatment option.1 ...

Developers of biosimilars will no longer be required to conduct clinical trials to prove effectiveness for FDA approval.